C219 - Therapy in Neurology III: Epilepsy and Headache
| Event Time: | Thursday May 9, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Epilepsy/Clinical Neurophysiology (EEG), Headache, Advanced Practice Provider, General Neurology: Overview |
| Director(s): | David Dodick MD, FAAN |
| Description: | Advances in headache therapy have been rapid over the recent past and will impact the practice of clinicians dealing with patients with primary and secondary headache disorders. Faculty will present an update on the most recent advances in the care of patients with major primary and secondary headache disorders and a strategy on how to optimize the use of long-established therapies. Advances in the medical and surgical management of epilepsy syndromes have been numerous over the recent past and will impact the practice of clinicians dealing with patients with seizures and epilepsy syndromes. Faculty will present an update on the most recent advances in the care of patients with seizure disorders and epilepsy syndromes disorders and a strategy on how to intengrate these advances in clinical practice. This program complements Therapy in Neurology I: Neurological Infectious Disease and Neuro-oncology, Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease, and Therapy in Neurology IV: Movement Disorders and Stroke, but covers independent topics. |
| Completion Message: | Participants should be able to implement an evidence-based treatment approach to major primary and secondary headache disorders; describe the most recent pharmacologic and non-pharmacologic treatment advances and how to best integrate them into clinical practice; describe the medical and surgical advances in the treatment of epilepsy; and implement an individualized and evidence-based treatment approach to patients presenting with seizure disorders in clinical practice. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:45 PM | Epilepsy Therapy | Joseph I. Sirven MD, FAAN |
| 1:45 PM - 2:00 PM | Questions and Answers | Joseph I. Sirven MD, FAAN |
| 2:00 PM - 2:45 PM | Headache Therapy | Peter Goadsby MD, PhD |
| 2:45 PM - 3:00 PM | Questions and Answers | Peter Goadsby MD, PhD |
| Speaker | Disclosure |
|---|---|
| Peter Goadsby, MD, PhD | Dr. Goadsby has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Reports grants and personal fees from Amgen and Eli Lilly and Company, and personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Biohaven Pharmaceuticals Inc., Dr Reddy's Laboratories, Electrocore LLC, eNeura, Impel NeuroPharma, MundiPharma, Novartis, Teva Pharmaceuticals, Trigemina Inc., medicolegal expert advice, Massachusetts Medical Society, UpToDate, Oxford University Press, and Wolters Kluwer; he holds a patent for magnetic stimulation for headache assigned to eNeura without fee.. Dr. Goadsby has received personal compensation in an editorial capacity for Journal Watch- Massachusetts Medical Society. Dr. Goadsby has received research support from Amgen and Eli-Lilly and Company. |
| Joseph I. Sirven, MD, FAAN | Dr. Sirven has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C244 -
Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases
Matthew Hoerth MD |
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
C250 -
Update in Epilepsy
Joseph Sirven MD, FAAN |
|
S59 -
Migraine: Impact, Treatment Patterns and Resource Utilization
|